Gadolinium Lawyer

How will my doctor know if I am suseptible to NSF before using gadolinium in an MRI?
****************************************************************************
Unless you to your physician, he or she will not know so it’s important to communicate if you have any kidney problems before having an MRI.  To learn more, contact a Gadolinium Lawyer at Williams Kherkher.

[Read more →]

Is there a safer alternative contrast agent that can be used in MRI studies?
********************************************************************
No, at present, Gadolinium is the agent being used.  To learn more, call the Gadolinium Lawyers at Williams Kherkher.

[Read more →]

Reporting in the October issue of the American Journal of Dermatopathology, Researchers at Wake Forest University, Baptist Medical Center suggest a possible explanation for why some patients on kidney dialysis who are injected with a “contrast agent” during a magnetic resonance imaging (MRI) develop nephrogenic systemic fibrosis (NSF). a rare tightening and swelling of the […]

[Read more →]

The U.S. Food and Drug Administration (FDA) first notified health care professionals and the public about the gadolinium-related risks for NSF in June 2006 and updated the information in December.When patients undergo an MRI, gadolinium-based contrast agents are commonly used to improve the visibility of internal structures. Five gadolinium-based contrast agents have been approved for […]

[Read more →]

The U.S. Food and Drug Administration (FDA) have asked manufacturers of all gadolinium-based contrast agents to include a new boxed warning on the product labeling. These agents are used to enhance the quality of magnetic resonance imaging (MRI).The warning states that patients with severe kidney insufficiency are at risk for developing a debilitating, and a […]

[Read more →]